1
|
Fairweather I, Brennan GP, Hanna REB, Robinson MW, Skuce PJ. Drug resistance in liver flukes. Int J Parasitol Drugs Drug Resist 2020; 12:39-59. [PMID: 32179499 PMCID: PMC7078123 DOI: 10.1016/j.ijpddr.2019.11.003] [Citation(s) in RCA: 84] [Impact Index Per Article: 21.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2019] [Revised: 11/19/2019] [Accepted: 11/20/2019] [Indexed: 02/07/2023]
Abstract
Liver flukes include Fasciola hepatica, Fasciola gigantica, Clonorchis sinensis, Opisthorchis spp., Fascioloides magna, Gigantocotyle explanatum and Dicrocoelium spp. The two main species, F. hepatica and F. gigantica, are major parasites of livestock and infections result in huge economic losses. As with C. sinensis, Opisthorchis spp. and Dicrocoelium spp., they affect millions of people worldwide, causing severe health problems. Collectively, the group is referred to as the Food-Borne Trematodes and their true significance is now being more widely recognised. However, reports of resistance to triclabendazole (TCBZ), the most widely used anti-Fasciola drug, and to other current drugs are increasing. This is a worrying scenario. In this review, progress in understanding the mechanism(s) of resistance to TCBZ is discussed, focusing on tubulin mutations, altered drug uptake and changes in drug metabolism. There is much interest in the development of new drugs and drug combinations, the re-purposing of non-flukicidal drugs, and the development of new drug formulations and delivery systems; all this work will be reviewed. Sound farm management practices also need to be put in place, with effective treatment programmes, so that drugs can be used wisely and their efficacy conserved as much as is possible. This depends on reliable advice being given by veterinarians and other advisors. Accurate diagnosis and identification of drug-resistant fluke populations is central to effective control: to determine the actual extent of the problem and to determine how well or otherwise a treatment has worked; for research on establishing the mechanism of resistance (and identifying molecular markers of resistance); for informing treatment options; and for testing the efficacy of new drug candidates. Several diagnostic methods are available, but there are no recommended guidelines or standardised protocols in place and this is an issue that needs to be addressed.
Collapse
Affiliation(s)
- I Fairweather
- School of Biological Sciences, The Queen's University of Belfast, 19 Chlorine Gardens, Belfast, BT9 5DL, UK.
| | - G P Brennan
- School of Biological Sciences, The Queen's University of Belfast, 19 Chlorine Gardens, Belfast, BT9 5DL, UK
| | - R E B Hanna
- Veterinary Sciences Division, Agri-Food and Biosciences Institute (AFBI), Stormont, Belfast, BT4 3SD, UK
| | - M W Robinson
- School of Biological Sciences, The Queen's University of Belfast, 19 Chlorine Gardens, Belfast, BT9 5DL, UK
| | - P J Skuce
- Disease Control, Moredun Research Institute, Pentlands Science Park, Bush Loan, Penicuik, Edinburgh, EH26 0PZ, UK
| |
Collapse
|
2
|
Viviani P, Lifschitz AL, Maté ML, García JP, Lanusse CE, Virkel GL. Assessment of the pharmacological interactions between the nematodicidal fenbendazole and the flukicidal triclabendazole: In vitro studies with bovine liver microsomes and slices. J Vet Pharmacol Ther 2018; 41:476-484. [DOI: 10.1111/jvp.12492] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2017] [Accepted: 01/16/2018] [Indexed: 12/15/2022]
Affiliation(s)
- P. Viviani
- Facultad de Ciencias Veterinarias; Laboratorio de Farmacología; Centro de Investigación Veterinarias de Tandil (CIVETAN-CONICET-CICPBA); Universidad Nacional del Centro de la Provincia de Buenos Aires (FCV-UNCPBA); Tandil Argentina
| | - A. L. Lifschitz
- Facultad de Ciencias Veterinarias; Laboratorio de Farmacología; Centro de Investigación Veterinarias de Tandil (CIVETAN-CONICET-CICPBA); Universidad Nacional del Centro de la Provincia de Buenos Aires (FCV-UNCPBA); Tandil Argentina
| | - M. L. Maté
- Facultad de Ciencias Veterinarias; Laboratorio de Farmacología; Centro de Investigación Veterinarias de Tandil (CIVETAN-CONICET-CICPBA); Universidad Nacional del Centro de la Provincia de Buenos Aires (FCV-UNCPBA); Tandil Argentina
| | - J. P. García
- Facultad de Ciencias Veterinarias; Área Clínica de Grandes Animales; Universidad Nacional del Centro de la Provincia de Buenos Aires (FCV-UNCPBA); Tandil Argentina
| | - C. E. Lanusse
- Facultad de Ciencias Veterinarias; Laboratorio de Farmacología; Centro de Investigación Veterinarias de Tandil (CIVETAN-CONICET-CICPBA); Universidad Nacional del Centro de la Provincia de Buenos Aires (FCV-UNCPBA); Tandil Argentina
| | - G. L. Virkel
- Facultad de Ciencias Veterinarias; Laboratorio de Farmacología; Centro de Investigación Veterinarias de Tandil (CIVETAN-CONICET-CICPBA); Universidad Nacional del Centro de la Provincia de Buenos Aires (FCV-UNCPBA); Tandil Argentina
| |
Collapse
|
3
|
Leathwick DM, Luo D. Managing anthelmintic resistance-Variability in the dose of drug reaching the target worms influences selection for resistance? Vet Parasitol 2017; 243:29-35. [PMID: 28807306 DOI: 10.1016/j.vetpar.2017.05.032] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2017] [Revised: 05/29/2017] [Accepted: 05/29/2017] [Indexed: 10/19/2022]
Abstract
The concentration profile of anthelmintic reaching the target worms in the host can vary between animals even when administered doses are tailored to individual liveweight at the manufacturer's recommended rate. Factors contributing to variation in drug concentration include weather, breed of animal, formulation and the route by which drugs are administered. The implications of this variability for the development of anthelmintic resistance was investigated using Monte-Carlo simulation. A model framework was established where 100 animals each received a single drug treatment. The 'dose' of drug allocated to each animal (i.e. the concentration-time profile of drug reaching the target worms) was sampled at random from a distribution of doses with mean m and standard deviation s. For each animal the dose of drug was used in conjunction with pre-determined dose-response relationships, representing single and poly-genetic inheritance, to calculate efficacy against susceptible and resistant genotypes. These data were then used to calculate the overall change in resistance gene frequency for the worm population as a result of the treatment. Values for m and s were varied to reflect differences in both mean dose and the variability in dose, and for each combination of these 100,000 simulations were run. The resistance gene frequency in the population after treatment increased as m decreased and as s increased. This occurred for both single and poly-gene models and for different levels of dominance (survival under treatment) of the heterozygote genotype(s). The results indicate that factors which result in lower and/or more variable concentrations of active reaching the target worms are more likely to select for resistance. The potential of different routes of anthelmintic administration to play a role in the development of anthelmintic resistance is discussed.
Collapse
Affiliation(s)
- Dave M Leathwick
- AgResearch, Grasslands Research Centre, Private Bag 11008, Palmerston North 4442, New Zealand.
| | - Dongwen Luo
- AgResearch, Grasslands Research Centre, Private Bag 11008, Palmerston North 4442, New Zealand
| |
Collapse
|
4
|
Novobilský A, Höglund J. First report of closantel treatment failure against Fasciola hepatica in cattle. INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE 2015; 5:172-7. [PMID: 26448903 PMCID: PMC4572398 DOI: 10.1016/j.ijpddr.2015.07.003] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/24/2015] [Revised: 07/29/2015] [Accepted: 07/30/2015] [Indexed: 11/30/2022]
Abstract
Control of Fasciola hepatica infection in livestock is based on annual treatment using flukicides such as triclabendazole, albendazole and closantel. However, triclabendazole resistant F. hepatica populations are emerging worldwide and resistance is emerging to albendazole, whereas it has until now never been described for closantel. In Sweden, a topical formulation containing a combination of closantel and ivermectin (Closamectin Pour On) has been registered for use in cattle only since 2011. This study evaluated the efficacy of closantel against F. hepatica in naturally infected beef cattle using both coproantigen and faecal egg count reduction tests. Faecal egg counts (FEC) and coproantigen ELISA examinations were conducted in February 2014 in three beef cattle herds (A, B, C) in south-western Sweden. On each farm, 10 F. hepatica coproantigen-positive and F. hepatica egg-positive animals were allocated after 12-16 weeks of housing into groups and treated topically with a minimum of 20 mg closantel per kg body weight. Faecal samples were collected from selected animals on 0, 7 and 21 day post-treatment (PT). Based on FEC, closantel efficacy 21 days PT was 72% (95% CI: 65-77%) and 97% (95% CI: 95-98%) on farms A and B, respectively. No FEC reduction at all was observed on farm C. In total, 4, 1 and 6 animals remained coproantigen-positive at 21 days PT on farms A, B and C, respectively. Closantel treatment failure was confirmed on two of the farms. As the animals were housed 12-16 weeks before treatment and thereafter during the entire study, failure due to the presence of juvenile flukes was excluded. Although the cause of closantel failure currently remains unclear, development of resistance or/and absorption failure of topical administration should be considered. To our knowledge, this is the first report of closantel treatment failure against F. hepatica in cattle.
Collapse
Affiliation(s)
- Adam Novobilský
- Department of Biomedical Sciences and Veterinary Public Health, Section for Parasitology, Swedish University of Agricultural Sciences (SLU), 75007 Uppsala, Sweden
| | - Johan Höglund
- Department of Biomedical Sciences and Veterinary Public Health, Section for Parasitology, Swedish University of Agricultural Sciences (SLU), 75007 Uppsala, Sweden
| |
Collapse
|
5
|
Kishida K, Ohkusu-Tsukada K, Hori M, Konnai M, Abiko C, Suzuki Y, Yamanome Y, Yoshimura H, Michishita M, Takahashi K. Investigation of the roles of fascioliasis and food allergy in intrahepatic eosinophilic proliferative pylephlebitis in Japanese Black cattle. Vet J 2013; 196:160-6. [DOI: 10.1016/j.tvjl.2012.10.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2011] [Revised: 10/02/2012] [Accepted: 10/03/2012] [Indexed: 11/24/2022]
|
6
|
Geurden T, Bartram D, Van Brussel L, Bo L, Scott-Baird E, Rugg D. Evaluation of the comparative efficacy of a moxidectin plus triclabendazole pour-on solution against adult and immature liver fluke, Fasciola hepatica, in cattle. Vet Parasitol 2012; 189:227-32. [PMID: 22579500 DOI: 10.1016/j.vetpar.2012.04.019] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2012] [Revised: 04/16/2012] [Accepted: 04/16/2012] [Indexed: 11/16/2022]
Abstract
The objective of this study was to evaluate the efficacy of a pour-on solution containing moxidectin plus triclabendazole (MOX plus TCBZ) against immature and adult stages of the liver fluke in cattle and compare the efficacy with other commercially available preparations. To this end, 104 male Holstein-Friesian calves aged between 3 and 4 months, were randomly allocated to 13 groups of eight animals each, and infected with approximately 500 Fasciola hepatica metacercariae. One group remained untreated, four groups were treated with MOX plus TCBZ at a dose rate of 0.1 mL/kg, four other groups were treated with ivermectin (IVM) plus clorsulon injectable at a dose rate of 0.02 mL/kg, and the remaining four groups were treated with IVM plus closantel pour-on at a dose rate of 0.1 mL/kg. Each treatment was applied to one of the groups at 4 weeks, 6 weeks, 8 weeks and 12 weeks after the experimental infection. At necropsy (99-102 days after infection), all untreated animals were infected with a minimum of 30 flukes. The MOX plus TCBZ treated animals had significantly (P<0.0001) lower fluke counts compared to the untreated control animals at all time points after treatment. Efficacy against 8-week old and adult flukes was >99.5%. For 6-week old immature fluke, the efficacy was 98.0% and for 4-week old immature fluke the efficacy was 90.9%. The IVM plus closantel pour-on treated animals had significantly lower fluke counts compared to the untreated control animals for adult and 8-week old flukes (P<0.0001), and for 6-week old flukes (P=0.002). The efficacy was 26.8%, 68.2%, 90.6% and 99.3% against 4-week, 6-week and 8-week old immature flukes, and adult flukes respectively. The IVM plus clorsulon treated animals had significantly lower fluke counts compared to the untreated control animals for adult (P<0.0001) and 8-week old (P<0.05) flukes. The efficacy was 29.7%, 43.4%, 53.2% and 99.2% against 4-week, 6-week and 8-week old immature flukes, and adult flukes respectively. For treatments at 4, 6 and 8 weeks after infection, the fluke counts were significantly (P<0.0001) lower for the MOX plus TCBZ treatment than for IVM plus closantel or IVM plus clorsulon. The results confirm the high efficacy (>90%) of the MOX plus TCBZ pour-on combination against 4-week old to adult liver fluke in cattle. The IVM plus closantel pour-on combination was effective (>90%) against 8-week old and adult flukes, but had low efficacy against 4- and 6-week old fluke. The IVM plus clorsulon injectable combination was effective (>90%) against adult fluke only.
Collapse
Affiliation(s)
- Thomas Geurden
- Pfizer Animal Health, Veterinary Medicine Research and Development, Hoge Wei 10, 1930 Zaventem, Belgium.
| | | | | | | | | | | |
Collapse
|
7
|
Efficacy of abamectin against the fowl tick, Argas (Persicargas) persicus (Oken, 1818) (Ixodoidea: Argasidae). Parasitol Res 2011; 109:1113-23. [PMID: 21547393 DOI: 10.1007/s00436-011-2354-z] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2010] [Accepted: 03/15/2011] [Indexed: 10/18/2022]
Abstract
Abamectin, in aqueous solutions of dose rates 0.0625, 0.125, 0.25, 0.5, and 1 mL/L, was sprayed on different feeding stages of the tick Argas (P.) persicus. The results revealed a marked increase of immobile and dead male or female ticks following a single treatment with the above doses, particularly the higher ones, and during the 5 weeks after treatment. Abamectin seriously decreased the percentage of fed ticks as well as that of oviposition and hatching. A decrease in the amount of emitted coxal fluid was observed also following treatment. Although the amount of ingested blood increased following abamectin treatment, digestion remained similar. The study also revealed that spraying a dose of 0.5 mL/L of abamectin in fowl shelters, i.e., floor, walls, ceiling, etc., is sufficient to eradicate A. persicus population.
Collapse
|
8
|
Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle. Vet Parasitol 2009; 162:278-84. [DOI: 10.1016/j.vetpar.2009.03.032] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2008] [Revised: 03/06/2009] [Accepted: 03/16/2009] [Indexed: 11/20/2022]
|
9
|
Jackson A. IN THIS ISSUE - May 2009. Aust Vet J 2009. [DOI: 10.1111/j.1751-0813.2009.00426.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|